409 related articles for article (PubMed ID: 32838963)
1. NLRP12 in innate immunity and inflammation.
Tuladhar S; Kanneganti TD
Mol Aspects Med; 2020 Dec; 76():100887. PubMed ID: 32838963
[TBL] [Abstract][Full Text] [Related]
2. The NLRP12 inflammasome recognizes Yersinia pestis.
Vladimer GI; Weng D; Paquette SW; Vanaja SK; Rathinam VA; Aune MH; Conlon JE; Burbage JJ; Proulx MK; Liu Q; Reed G; Mecsas JC; Iwakura Y; Bertin J; Goguen JD; Fitzgerald KA; Lien E
Immunity; 2012 Jul; 37(1):96-107. PubMed ID: 22840842
[TBL] [Abstract][Full Text] [Related]
3. NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome.
Coombs JR; Zamoshnikova A; Holley CL; Maddugoda MP; Teo DET; Chauvin C; Poulin LF; Vitak N; Ross CM; Mellacheruvu M; Coll RC; Heinz LX; Burgener SS; Emming S; Chamaillard M; Boucher D; Schroder K
Sci Signal; 2024 Jan; 17(820):eabg8145. PubMed ID: 38261657
[TBL] [Abstract][Full Text] [Related]
4. The multifaceted nature of NLRP12.
Tuncer S; Fiorillo MT; Sorrentino R
J Leukoc Biol; 2014 Dec; 96(6):991-1000. PubMed ID: 25249449
[TBL] [Abstract][Full Text] [Related]
5. Characterization of NLRP12 during the in vivo host immune response to Klebsiella pneumoniae and Mycobacterium tuberculosis.
Allen IC; McElvania-TeKippe E; Wilson JE; Lich JD; Arthur JC; Sullivan JT; Braunstein M; Ting JP
PLoS One; 2013; 8(4):e60842. PubMed ID: 23577168
[TBL] [Abstract][Full Text] [Related]
6. NLRP12 negatively regulates proinflammatory cytokine production and host defense against Brucella abortus.
Silveira TN; Gomes MT; Oliveira LS; Campos PC; Machado GG; Oliveira SC
Eur J Immunol; 2017 Jan; 47(1):51-59. PubMed ID: 27800616
[TBL] [Abstract][Full Text] [Related]
7. Focus on negatively regulated NLRs in inflammation and cancer.
Wang J; He W; Li C; Ma Y; Liu M; Ye J; Sun L; Su J; Zhou L
Int Immunopharmacol; 2024 Jul; 136():112347. PubMed ID: 38820966
[TBL] [Abstract][Full Text] [Related]
8. Salmonella exploits NLRP12-dependent innate immune signaling to suppress host defenses during infection.
Zaki MH; Man SM; Vogel P; Lamkanfi M; Kanneganti TD
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):385-90. PubMed ID: 24347638
[TBL] [Abstract][Full Text] [Related]
9. NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways.
Platnich JM; Muruve DA
Arch Biochem Biophys; 2019 Jul; 670():4-14. PubMed ID: 30772258
[TBL] [Abstract][Full Text] [Related]
10. Nod-like Receptors: Critical Intracellular Sensors for Host Protection and Cell Death in Microbial and Parasitic Infections.
Babamale AO; Chen ST
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768828
[TBL] [Abstract][Full Text] [Related]
11. Myxoma virus lacking the pyrin-like protein M013 is sensed in human myeloid cells by both NLRP3 and multiple Toll-like receptors, which independently activate the inflammasome and NF-κB innate response pathways.
Rahman MM; McFadden G
J Virol; 2011 Dec; 85(23):12505-17. PubMed ID: 21957307
[TBL] [Abstract][Full Text] [Related]
12. Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure.
Coutermarsh-Ott S; Eden K; Allen IC
J Gen Virol; 2016 Apr; 97(4):825-838. PubMed ID: 26763980
[TBL] [Abstract][Full Text] [Related]
13. Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex.
Man SM; Hopkins LJ; Nugent E; Cox S; Glück IM; Tourlomousis P; Wright JA; Cicuta P; Monie TP; Bryant CE
Proc Natl Acad Sci U S A; 2014 May; 111(20):7403-8. PubMed ID: 24803432
[TBL] [Abstract][Full Text] [Related]
14. The role of NLRP12 in inflammatory diseases.
Huang L; Tao Y; Wu X; Wu J; Shen M; Zheng Z
Eur J Pharmacol; 2023 Oct; 956():175995. PubMed ID: 37572944
[TBL] [Abstract][Full Text] [Related]
15. Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis).
Sharma BR; Karki R; Rajesh Y; Kanneganti TD
J Biol Chem; 2023 Sep; 299(9):105141. PubMed ID: 37557956
[TBL] [Abstract][Full Text] [Related]
16. NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs.
Sundaram B; Pandian N; Mall R; Wang Y; Sarkar R; Kim HJ; Malireddi RKS; Karki R; Janke LJ; Vogel P; Kanneganti TD
Cell; 2023 Jun; 186(13):2783-2801.e20. PubMed ID: 37267949
[TBL] [Abstract][Full Text] [Related]
17. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
Lee S; Suh GY; Ryter SW; Choi AM
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
[TBL] [Abstract][Full Text] [Related]
18. Inflammasome biology, molecular pathology and therapeutic implications.
Awad F; Assrawi E; Louvrier C; Jumeau C; Georgin-Lavialle S; Grateau G; Amselem S; Giurgea I; Karabina SA
Pharmacol Ther; 2018 Jul; 187():133-149. PubMed ID: 29466702
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer.
Karan D; Tawfik O; Dubey S
Sci Rep; 2017 Jun; 7(1):4378. PubMed ID: 28663562
[TBL] [Abstract][Full Text] [Related]
20. The CARD plays a critical role in ASC foci formation and inflammasome signalling.
Proell M; Gerlic M; Mace PD; Reed JC; Riedl SJ
Biochem J; 2013 Feb; 449(3):613-21. PubMed ID: 23110696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
